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Anovulation is a common cause of female
infertility (1), and its frequency is reported
to increase when women are exposed to
reproductive toxicants (2). Environmental
exposures associated with anovulation in
women may occur in the home or the
workplace (3). A number of studies in labo-
ratory animals have suggested that environ-
mental chemicals may have adverse effects
on ovarian function that result in anovula-
tion and/or menstrual dysfunction (4). The
consequences of these perturbations are not
limited to infertility. For example, estrogen
deficiency may contribute to risk of cardio-
vascular disease and/or bone loss (5,6).
Anovulation is also associated with an
increased risk of breast cancer (7) and
endometrial cancer (8). Menstrual dysfunc-
tion, such as irregular uterine bleeding, can
result from causes other than ovarian dys-
function and also can be associated with
infertility (9,1Q). Epidemiologic studies that
rely solely on menstrual calendars to detect
adverse reproductive outcomes associated
with environmental exposures cannot dis-
tinguish between endocrine abnormalities
that may result from toxicity to reproduc-
tive organs and menstrual bleeding disor-
ders that may result from toxicity to other
organ systems (11).
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Although the occurrence of anovula-
tion in clinic populations can be docu-
mented by standard diagnostic procedures
including daily basal body temperature
assessments, daily measurements of serum
progesterone (Po), and ultrasound evalua-
tions (12), these methods are not feasible
for monitoring the reproductive function
of large groups of women in population-
based studies. Thus, urinary metabolites of
reproductive hormones are now being
measured as biomarkers of ovarian func-
tion and implantation in epidemiologic
studies (13,14). Methods have been devel-
oped to use the daily urinary levels of
estrogen and P metabolites for identifica-
tion of the approximate day of ovulation in
ovulatory menstrual cycles (15), but no
method is currently available for classifying
cycles as anovulatory on the basis of uri-
nary hormone measurements alone.
The present study was undertaken to
devise a simple algorithm, based on urinary
hormone assays, for identifying anovulato-
ry cycles, which may occur between
episodes of vaginal bleeding or which may
be associated with prolonged intervals of
amenorrhea. The method described here
can be used to identify periods of anovula-
tion or to screen cycles for evidence of ovu-
lation before the application of existing
algorithms for determining the approximate
day of ovulation and/or the occurrence of
early pregnancy loss in ovulatory cycles.
Methods
To develop the algorithm, six women who
had a recent history of exercise-induced
amenorrhea (absence of menstruation dur-
ing the preceding three months) were
recruited at Oregon State University. These
women provided daily urine samples, week-
ly blood samples, and completed a daily
menstrual calendar for a 40-day study peri-
od. These women exercised for an average
of 8.0 hr (SD 3.5) per week. Their mean
age was 23.3 years (SD 4.0), with a range of
19-29 years, and they were in good general
health.
Each woman collected first-void morning
urine samples every day for 40 consecutive
days and stored them in a freezer (-20°C)
until analyzed. In addition, 4 weekly blood
samples were collected, beginning on day 17
of the 40-day study period. The blood sam-
ples were allowed to clot, and serum was
removed and stored frozen until analyzed.
The weekly blood samples were used to veri-
fy that there was no significant rise in P pro-
duction (i.e., P <2 ng/ml) during the study
interval. Although such anovulatory inter-
vals during periods of amenorrhea cannot be
considered menstrual cycles, we use the term
"cycles" to refer to the urine collection inter-
vals, whether or not vaginal bleeding
occurred.
To test the validity of the PdG ratio
algorithm for identifying anovulatory
cycles, a second set of urine samples was
collected from an independent group of 40
women participating in a study of the
effects of exercise on ovarian function at the
University of Connecticut Health Center.
First-void morning urine samples were col-
lected daily by 38 women during 85 men-
strual cycles, and by 2 women who experi-
enced no vaginal bleeding during the study.
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Each amenorrheic woman collected 2 con-
secutive sets of 30 daily urine samples. All
40 women also provided weekly blood
samples. These women ranged in age from
19 to 36 years with a mean age of 28.2 (SD
5.8) years. Fourteen women were recre-
ational athletes who ran up to 20 miles per
week, 15 were conditioned athletes who
ran more than 20 miles per week, and 11
women were sedentary. Altogether, they
contributed 89 collection cycles. All
women enrolled in the study gave
informed, written consent, and the research
protocols were reviewed and approved by
the institutional review boards of the
respective universities.
The protocol for urine and blood col-
lections in the University of Connecticut
Health Center group was the same as in
the group of women from Oregon State
University, except that sampling was begun
on the first day of vaginal bleeding and was
divided into cycles based on the subsequent
occurrences of menstrual bleeding. In col-
lection periods in which there was no
bleeding for 30 days (amenorrhea), a new
sampling interval was begun. In addition to
providing daily urine samples and weekly
blood samples, each woman completed a
daily record of menstrual bleeding for the
duration of the study.
We analyzed each serum sample for P
using commercial radioimmunoassay kits
(16). Urinary pregnanediol-3-glucuronide
(PdG) and creatinine (CR) levels for each
urine sample were determined by methods
described by Munro et al. (17). Each PdG
concentration was indexed by the CR con-
centration of the same sample to adjust for
urine dilution. Urine samples with CR con-
centrations <0.2 mg/ml were considered
too dilute for accurate analysis, and samples
with CR concentrations >3.0 mg/ml were
considered too concentrated; neither type of
sample was induded in the analysis.
The development of the algorithms is
based on the assessment of P secretion by
the corpus luteum during the post-ovulato-
ry phase of the menstrual cycle. Because P
is not expected to be metabolized and/or
excreted in the same way by every woman,
it was necessary to develop an approach for
assessing P production that could utilize
measurements of a single P metabolite
(PdG), but could not be confounded by
individual variation in hormone metabo-
lism and excretion. The method takes
advantage of the single source and relative-
ly uniform production of P from the
adrenal gland before ovulation (18). A
mean 5-day baseline value for the excretion
of PdG was calculated for each cycle and
used as a denominator for the calculation
of PdG ratios for that cycle. The ratios
constitute a series of dimensionless values
that can be used to characterize P metabo-
lite excretion throughout the cycle. A sus-
tained increase in these values should be
observed when P production by the corpus
luteum after ovulation exceeds its secretion
by the adrenal gland.
Two algorithms to assess anovulatory
cycles using urinary levels of PdG/CR were
developed and evaluated for sensitivity and
specificity by comparison to the "gold stan-
dard" of weekly serum P levels. The first
algorithm (cycles method) was developed
for use when intermenstrual intervals were
well defined by menstrual bleeding and
were assumed to represent menstrual cycles.
The second algorithm (interval method)
was developed for use with samples collect-
ed during periods when menstruation could
not be dearly identified, i.e., during inter-
vals of amenorrhea or intermittent vaginal
bleeding. All cycles/intervals were evaluated
separately by both the cycles method and
the interval method.
For the cycles method, the PdG base-
line was defined as the average of the daily
concentrations of PdG/CR from cycle day
6 through cycle day 10, where day 1 was
the first day of vaginal bleeding. This base-
line represents an interval in the follicular
phase, which begins after dearance of PdG
from the previous luteal phase and ends
before the rise of PdG at the time of ovula-
tion. During this period, the adrenal gland,
not the ovary, is the primary source of P
production (19). The ratios of subsequent
daily PdG/CR concentrations to this base-
line value were calculated beginning with
cycle day 11 and were continued to the end
of the cycle (day before the first day of the
next vaginal bleeding).
For the interval method, the PdG base-
line was determined by calculating a series
of centered 5-day moving averages of daily
concentrations of PdG/CR, beginning with
day 3 of collection and was continued to
day n - 2 (where n = the last day of collec-
tion). We used the lowest of these 5-day
average values as the PdG baseline. Daily
PdG ratios were computed with the inter-
val method for all collection intervals
beginning with day 1 of the collection peri-
od and was continued to the end of the
collection period.
Cigarette smoking is a potential con-
founding variable that needed to be taken
into account in designing the PdG ratio
algorithm because smoking has been shown
to increase P production by the adrenal
gland by as much as 65% (20-22). To test
the potential effects of smoking and the
resulting increase in urinary PdG concen-
tration on the PdG ratio algorithm, PdG
values were increased artificially (since
none of the women studied actually
smoked) for all 89 cycles obtained from the
40 University of Connecticut Health
Center women. The values for the PdG
baseline were increased by 75%, which
assumed an increment greater than the
maximum reported increase of 65% (20),
as well as 100% recovery of circulating
adrenal P as urinary PdG. The PdG/CR
concentrations for the other days of the
collection period were also increased by the
same amount, which was used to adjust the
baseline (75% of the baseline value). Daily
PdG ratios then were computed for all
cycles using the interval method as
described previously.
Sensitivity, specificity, and confidence
intervals (23) for the urinary PdG ratio
algorithm were computed for identifying
anovulatory cycles in the second set of 40
women, using each of the three procedures
described above. The "gold standard" used
for the analysis was weekly serum P values
for each of the 89 cycles. A cycle was classi-
fied as anovulatory if P levels in the weekly
blood samples never exceeded 2 ng/ml (12).
Results
The weekly serum P values for the six
women with presumed anovulation in the
Oregon State University study group ranged
from 0.186 ng/ml to 1.276 ng/ml, confirm-
ing the absence of ovulation during the 40-
day urine collection period. When the cydes
method was used to evaluate the PdG ratios,
in only 1 of 6 cases was the PdG ratio .2.5
on 2 consecutive days, and the PdG ratio
was never >2.5 on 3 consecutive days (Table
1). When calculated by the interval method,
the PdG ratio was never >2.5 on 3 consecu-
tive days (Table 2). Based on these data, an
algorithm rule was formulated that dassified
cycles with PdG ratios .3.0 for .3 consecu-
tive days as ovulatory; otherwise, cycles were
dassified as anovulatory.
Table 1. Development of the PdG ratio algorithm
from anovulatory intervals (n = 6): cycles method8
No. consecutive days with
values 2PdG ratio on
Value of the corresponding axisb
PdGratio 1 2 3 4 5 6
1.0 6 4 4 4 3 3
1.5 4 3 3 1 0 0
2.0 3 2 1 0 0 0
2.5 3 1 0 0 0 0
3.0 0 0 0 0 0 0
PdG, pregnanediol-3-glucuronide.
"Each cell represents total number of anovulatory
intervals that meet the criteria of the two axes.
Cycles method: baseline = mean of PdG/creati-
nine values for cycle days 6 to 10, day 1 = day of
menses.
bDay 11 to end of collection interval.
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To test the sensitivity and specificity of
the algorithm, the 89 cycles from the sec-
ond set of women at the University of
Connecticut Health Center were divided
into ovulatory and anovulatory cycles based
on serum P measurements. Twelve cycles
from 9 women had serum P <2 ng/ml in all
weekly samples and were classified as
anovulatory; 2 of these women contributed
only anovulatory intervals. The remaining
77 cycles had 1 or more weekly serum P
values >2 ng/ml and were classified as ovu-
latory. Of the 77 ovulatory cycles, 10 were
contributed by 7 women who also had
anovulatory cycles; the other 67 ovulatory
cycles were provided by the remaining 31
women. One cycle from the 77 ovulatory
Table 2. Development of the PdG ratio algorithm
from anovulatory intervals (n = 6): interval methoda
No. consecutive days with
values 2PdG ratio on
Value of the corresponding axisb
PdGratio 1 2 3 4 5 6
1.0 6 6 6 6 6 6
1.5 6 6 6 5 4 3
2.0 6 5 5 4 3 2
2.5 5 5 2 0 0 0
3.0 5 3 0 0 0 0
3.5 4 2 0 0 0 0
4.0 4 0 0 0 0 0
4.5 3 0 0 0 0 0
5.0 1 0 0 0 0 0
5.5 0 0 0 0 0 0
PdG, pregnanediol-3-glucuronide.
aEach cell represents total number of anovulatory
intervals that meet the criteria of the two axes.
Interval method: baseline = lowest 5-day moving
average from day 3 to day n- 2 of collection, where
n = number of days urine samples collected.
bDay 1 to end of collection interval.
cycles had missing urine samples during the
follicular phase and was not used in subse-
quent analysis by the cycles method but was
evaluated using the interval method.
Nine of the 12 cycles dassified as anovu-
latory on the basis of weekly serum P mea-
surements were also dassified as anovulatory
by the PdG ratio algorithm (Table 3).
However, 3 of the 12 cycles were misdassi-
fied as ovulatory by the PdG ratio algo-
rithm. Evaluation of the PdG profiles in
these misclassified cycles revealed transient
elevations (<7 days) of urinary PdG in the
sampling period (Fig. 1). The maximum
PdG levels of these elevations ranged from
2.5 pg/mg CR to 8.7 pg/mg CR (mean =
4.9 pg/mg Cr, SD 2.7). In comparison, the
maximum PdG levels in the 77 ovulatory
cycles ranged from 0.85 to 15.38 pg/mg CR
(mean = 6.4 pg/mg Cr, SD 3.0). In two of
the three misdassified cycles, there was evi-
dence of menstruation as a result of P with-
drawal, because vaginal bleeding followed
the period of PdG elevation (Fig. 1).
However, this luteal function was not
detected by serum P because it occurred
during the time when no blood samples
were collected, i.e., between weekly blood
samples (Fig. 1). Had more frequent blood
samples been obtained, it is likely that these
two cycles would have been dassified as ovu-
latory with a short luteal phase. In the third
misdassified interval, the daily PdG profile
revealed evidence of transient luteal func-
tion, but there was no record of occurrence
of vaginal bleeding. Again, the rise of PdG
occurred between the weekly blood samples,
so the corresponding P value was not
obtained (Fig. 1). This woman was amenor-
rheic, with the last documented menses 15
months before enrollment in this study.
Table 3. Sensitivity and specificity of the PdG ratio algorithm to detect anovulatory menstrual cycles:
cycles methoda
Serum progesteronec
Urinary PdG ratio algorithmb Anovulatory Ovulatory Total
All cycles Anovulatory 9 8 17
Ovulatory 3d 68 71
12 76 88
Sensitivity (95% Cl) = 75% (42.8-94.5)
Specificity (95% Cl) = 89.47% (80.1-95.3)
First cycles Anovulatory 3 4 7
Ovulatory 3d 30 33
6 34 40
Sensitivity (95% Cl) = 50% (11.8-88.2)
Specificity (95% Cl) = 88.24% (72.5-96.7)
PdG, pregnanediol-3-glucuronide.
aCycles method: baseline PdG = mean of daily PdG/creatinine values from day 6 to day 10, day 1 = day of
menses. PdG ratios calculated beginning day 11 to day before next menses or to the end of the collection
period. All cycles .19 days.
bCycles with PdG ratios .3 for .3 consecutive days were classified as ovulatory; otherwise, anovulatory
by the urinary PdG ratio algorithm.
cCycles with all weekly serum samples <2 ng/ml progesterone were classified as anovulatory; otherwise,
ovulatory.
dMisclassified cycles: cycles A, B, and C (see Fig. 1).
Urinary PdG ratios also were calculated
for 76 of the 77 cycles dassified as ovulato-
ry on the basis of weekly serum P levels. In
8 of these 76 cycles the PdG ratio algorithm
misclassified the intervals as anovulatory.
Thus, using the serum P values as the "gold
standard," the sensitivity and specificity of
the PdG ratio algorithm to identify anovu-
latory intervals using the cycles method
were 75% and 89.5%, respectively (Table
3). Because some women contributed mul-
tiple cycles, the data were recalculated to
address the issue of potential lack of inde-
pendence of collected cycles. For these cal-
culations, only the first cycle provided by
each of the 40 women was used, and the
resulting sensitivity and specificity of the
PdG/CR ratio algorithm were 50% and
88.2%, respectively (Table 3).
Table 4 provides information on the
sensitivity and specificity of the PdG ratio
algorithm as evaluated by the interval
method for the same 89 cycles. The sensi-
tivity and specificity for all intervals were
75% and 92.2%, respectively. When these
data were recalculated using only the first
cycle from each of the 40 women, the sen-
sitivity and specificity of the PdG ratio
algorithm were 50% and 94.1%, respec-
tively.
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Figure 1. Misclassified cycles. Cycle A and cycle
B are menstrual cycles, cycle C is an amenorrhe-
ic interval. PdG, pregnanediol-3-glucuronide; CR,
creatinine; P, progesterone.
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When the artificial adjustment in urinary
PdG values was made to simulate increased
adrenal production of P as a result of smok-
ing, the sensitivity using the interval method
was stil 75%, but the specificity dropped to
84.4% (Table 5). The loss of specificity was
due to an increase in the number of misclas-
sified ovulatory cycles from 6 cycles to 12
cycles. When only the first cycle for each
woman was examined using the interval
method, the specificity was 85.3%, with no
change in sensitivity (Table 5).
Discussion
The algorithm described here is designed to
detect anovulatory menstrual cycles and
Table 4. Sensitivity and specificity of the PdG ratio algorithm to detect anovulatory menstrual cycles: inter-
val method"
Serum progesteronec
Urinary PdG ratio algorithmb Anovulatory Ovulatory Total
All cycles Anovulatory 9 6 15
Ovulatory 3d 71 74
12 77 89
Sensitivity (95% Cl) = 75% (42.8-94.5)
Specificity (95% Cl) = 92.2% (83.6-97.0)
First cycles Anovulatory 3 2 5
Ovulatory 3d 32 35
6 34 40
Sensitivity (95% Cl) = 50% (11.8-88.2)
Specificity (95% Cl) = 94.12% (80.2-99.2)
PdG, pregnandiol-3-glucuronide.
8lnterval method: baseline = lowest 5-day moving average of daily concentrations of PdG/creatinine from
day 3 to day n - 2 of collection (n = number of days of urine samples collected). PdG ratios calculated
beginning day 1 of the collection to the end of the collection period. All cycles .19 days.
bCycles with PdG ratios .3 for .3 consecutive days were classified as ovulatory; otherwise, anovulatory
by the urinary PdG ratio algorithm.
cCycles with all weekly serum samples <2 ng/ml progesterone were classified as anovulatory; otherwise,
ovulatory.
dMisclassified cycles: cycles A, B, and C (see Fig. 1).
Table 5. Sensitivity and specificity of the PdG ratio algorithm to detect anovulatory menstrual cycles: inter-
val method adjusted for smokinga
Serum progesteronec
Urinary PdG ratio algorithmb Anovulatory Ovulatory TotalAll
All cycles Anovulatory 9 12 21
Ovulatory 3d 65 68
12 77 89
Sensitivity (95% Cl) = 75% (42.8-94.5)
Specificity (95% Cl) = 84.42% (74.1-91.6)
First cycles Anovulatory 3 5 8
Ovulatory 3d 29 32
6 34 40
Sensitivity (95% Cl) = 50% (11.8-88.2)
Specificity (95% Cl) = 85.29% (68.9-95.1)
PdG, pregnandiol-3-glucuronide.
alnterval method with data artificially adjusted to simulate smoking-induced increase in adrenal produc-
tion of progesterone: adjusted baseline = lowest 5-day moving average of daily concentrations of
PdG/creatinine from day 3 to day n - 2 of collection + 75% increase (n = number of days of urine samples
collected). Adjusted daily PdG/creatinine + 75% of lowest 5-day moving average (increased adrenal con-
tribution throughout the collection period). PdG ratios calculated beginning day 1 of collection to the end
of the collection period. All cycles .19 days.
bCycles with PdG ratios .3 for .3 consecutive days were classified as ovulatory; otherwise, anovulatory
by the urinary PdG ratio algorithm.
cCycles with all weekly serum samples <2 ng/ml progesterone were classified as anovulatory; otherwise,
they were ovulatory.
dMisclassified cycles: cycles A, B, and C (see Fig. 1).
reflects P secretion by the corpus luteum
after ovulation. The algorithm is based on
detection of a sustained increase in urinary
PdG excretion in excess of the basal levels.
Because P is not metabolized and/or excret-
ed in the same way by every individual, it is
necessary to employ an approach for assess-
ing P production that is not confounded by
individual variation in steroid hormone
metabolism and excretion. The PdG ratio
algorithm takes advantage of the single
source and relatively uniform production of
P from the adrenal gland before ovulation
(18). When intermenstrual intervals are
well defined, a baseline value for the excre-
tion of PdG is calculated for the first phase
of each intermenstrual interval. In women
with amenorrhea or metrorrhagia, a base-
line value is generated by searching for the
lowest 5-day interval of PdG excretion
within the period of urine collection. In this
latter application, the number of days of
urine collection must be large enough to
avoid the false identification of anovulation
that would result if the collection interval
contained only a follicular phase.
The daily PdG ratios constitute a series
of dimensionless values that are used to
characterize P metabolite excretion
throughout the cycle. The advantages of
this algorithm are 1) it is based on a well-
defined physiologic process that is relatively
uniform between individual women; 2) it
requires daily measurement of only one
40
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Figure 2. (A) Distribution of the median day of the
lowest 5-day moving average and (B) distribution
of the cycle lengths for all 89 cycles collected.
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Figure 2 shows the location in the cycle
of the PdG baseline for the interval method
when it was determined from the 5-day
moving average of the PdG/CR values.
These data are shown as the distribution of
the median day of the lowest 5-day average.
Figure 2 also shows the distribution of the
cycle lengths of the 89 cycles studied. The
median day of the lowest 5-day moving
average occurred by day 10 of collection in
73% of the cycles and by day 15 of collec-
tion in 91% of the cycles. The cycle length
ranged from 19 days to 50 days with a
mean of 27.9 (SD 4.8) days, and 89% of
the cycles had cycle lengths between 24
days and 32 days.
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hormone analyte and creatinine; and 3) it
attenuates individual differences in steroid
metabolism and route of steroid metabolite
excretion by relying on the relative change
in analyte excretion rather than absolute
urinary concentrations, which can be influ-
enced by environmental factors such as
smoking (20-22. Using this algorithm, a
sustained increase in the PdG ratio is
observed when P production by the corpus
luteum after ovulation exceeds its secretion
by the adrenal gland.
Theoretically, changes in P secretion by
the adrenal gland could affect the values of
PdG ratio through changes in the baseline
values. Cigarette smoking has been shown
to alter adrenal gland P production (20-22),
but our calculations demonstrate that even a
75% increase in the adrenal source ofP does
not significantly affect the sensitivity and
specificity of the PdG algorithm.
The PdG ratios that are generated for
use in the algorithm are largely unaffected
by individual differences in P metabolism
and route of excretion. The impact of these
variables can be demonstrated by analysis
of the daily values for absolute concentra-
tions of PdG/CR in the same sets of cycles
studied with the PdG ratio algorithm.
Evaluation of the six anovulatory cycles
from Oregon State University by the meth-
ods previously described led to an absolute
cut-off level for ovulatory cycles of PdG .3
pg/mg CR for .3 consecutive days (data
not shown). When this rule was applied to
the 89 cycles from the University of
Connecticut Health Center, 11 of the 12
anovulatory cycles were correctly identi-
fied, but 18 of the 77 ovulatory cycles were
misdassified as anovulatory. This relatively
low specificity of 76.6% was increased to
approximately 90% when PdG ratios
instead of absolute cut-offs were used in
the algorithm (Tables 3 and 4).
In recent population-based studies of
reproductive health in women potentially
exposed to environmental hazards, a
prospective approach has been taken in
which daily urine samples have been col-
lected and analyzed for biomarkers of ovu-
lation and early pregnancy loss
(13,14,24,25). The algorithm we report
here can be used for the initial assessment
of ovulatory function in such studies. The
detection of anovulatory cycles may be the
primary endpoint for studies that focus on
ovarian function. Such cycles could be
evaluated further with additional biomark-
ers to determine whether the cause of
anovulation was ovarian failure or pituitary
dysfunction. In studies to assess early fetal
loss, early identification of anovulatory
cycles is a cost-effective strategy because
these cycles can be excluded from subse-
quent laboratory evaluation for conception
and loss. The high specificity of the algo-
rithm is particularly advantageous for such
screening applications, since few ovulatory
cycles will be misclassified as anovulatory.
Some women contributed multiple
cycles in this study, and the data therefore
were analyzed in two ways, using data from
all cycles contributed by the 40 women,
and using data from only the first cycle
contributed by each woman to control for
the lack of independence of multiple
cycles contributed by the same woman.
The results of the present study demon-
strate that the PdG ratio algorithm has
good sensitivity to identify anovulatory
cycles. The sensitivity of 75% for all cycles
and 50% for the first cycle determined
from the data in this study is probably an
underestimate of the true sensitivity of the
method, as indicated by further evaluation
of the misclassified cycles. Examination of
the urinary hormone profiles for two of the
three misclassified cycles (Fig. 1) revealed
evidence for significant urinary PdG excre-
tion (and thus P production) between days
of blood collection, and a period of vaginal
bleeding that was consistent with P with-
drawal. Because of the brief interval of
luteal function in these cycles, evidence of P
secretion was not obtained with weekly
serum samples. Although no vaginal bleed-
ing was associated with the rise of PdG in
the third misclassified cycle, it is likely that
a significant increase in P secretion also
would have been detected in this cycle if
blood samples had been collected more fre-
quently. Whether or not ovulation occurred
in the third misclassified cycle, the cycle
dearly did not have a normal luteal phase,
as the PdG elevation was much shorter in
duration than has been observed in docu-
mented ovulatory cycles (17).
The hormone profiles in Figure 1
demonstrate the heterogeneity of cycles
that may be classified as "ovulatory" by the
PdG ratio algorithm. As indicated by the
high specificity of the algorithm, virtually
all episodes of normal luteal function are
likely to be identified by this method.
Whether episodes of transient luteal func-
tion are always a result of ovulation is
unclear. However, brief intervals of luteal
function, such as those illustrated in Figure
1, are not likely to be fertile cycles, and
thus cycles identified as ovulatory by this
PdG ratio algorithm cannot necessarily be
assumed to be normal cycles (26,27). In
future studies, additional algorithms will be
developed to analyze ovulatory intervals for
identification of normal and abnormal
luteal phases.
Previous attempts to document the
occurrence of abnormal menstrual cycles in
population-based studies have been limited
to analyses of menstrual calendars or daily
diaries (28,29). Anovulation has been sug-
gested to underlie menstrual cycles that are
unusually long (30) and unusually short
(31). However, it is generally agreed that
menstrual cycle data alone are not adequate
for accurate detection of anovulation (34.
Recent studies have demonstrated the feasi-
bility of collecting daily urine samples in
large population-based studies (13,14,24,
25). The methodology described here can
be used to process and screen those samples
in a cost-effective manner and to analyze
the data to identify anovulatory cycles with
a high degree of sensitivity and specificity
without a requirement for blood sampling.
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